{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:51:07Z","timestamp":1778647867976,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Richard K. Gershon, MD, Student Research Fellowship"},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["T35AG049685"],"award-info":[{"award-number":["T35AG049685"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30 EY02687"],"award-info":[{"award-number":["P30 EY02687"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s00417-022-05849-6","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T08:04:59Z","timestamp":1666339499000},"page":"699-708","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The influence of the topographic location of geographic atrophy on vision-related quality of life in nonexudative age-related macular degeneration"],"prefix":"10.1007","volume":"261","author":[{"given":"Aneesha","family":"Ahluwalia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangbo L.","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihan","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengyuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin K.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael M.","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucian V.","family":"Del Priore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,21]]},"reference":[{"issue":"2","key":"5849_CR1","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, Wong TY (2014) Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2(2):e106-116. https:\/\/doi.org\/10.1016\/S2214-109X(13)70145-1","journal-title":"Lancet Glob Health"},{"issue":"3","key":"5849_CR2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ophtha.2017.08.038","volume":"125","author":"M Fleckenstein","year":"2018","unstructured":"Fleckenstein M, Mitchell P, Freund KB, Sadda S, Holz FG, Brittain C, Henry EC, Ferrara D (2018) The progression of geographic atrophy secondary to age-related macular degeneration. Ophthalmology 125(3):369\u2013390. https:\/\/doi.org\/10.1016\/j.ophtha.2017.08.038","journal-title":"Ophthalmology"},{"issue":"5","key":"5849_CR3","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1001\/jamaophthalmol.2021.0146","volume":"139","author":"L Assi","year":"2021","unstructured":"Assi L, Chamseddine F, Ibrahim P, Sabbagh H, Rosman L, Congdon N, Evans J, Ramke J, Kuper H, Burton MJ, Ehrlich JR, Swenor BK (2021) A global assessment of eye health and quality of life: a systematic review of systematic reviews. JAMA Ophthalmol 139(5):526\u2013541. https:\/\/doi.org\/10.1001\/jamaophthalmol.2021.0146","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"5849_CR4","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1080\/09286586.2020.1863992","volume":"28","author":"N Khachatryan","year":"2021","unstructured":"Khachatryan N, Pistilli M, Maguire MG, Chang AY, Samuels MR, Mulvihill K, Salowe RJ, O\u2019Brien JM (2021) A Review of studies of the association of vision-related quality of life with measures of visual function and structure in patients with glaucoma in the United States. Ophthalmic Epidemiol 28(3):265\u2013276. https:\/\/doi.org\/10.1080\/09286586.2020.1863992","journal-title":"Ophthalmic Epidemiol"},{"issue":"14","key":"5849_CR5","doi-asserted-by":"publisher","first-page":"6298","DOI":"10.1167\/iovs.16-20361","volume":"57","author":"M Kimel","year":"2016","unstructured":"Kimel M, Leidy NK, Tschosik E, Dolan C, Souied EH, Varma R, Bressler NM (2016) Functional reading independence (FRI) index: a new patient-reported outcome measure for patients with geographic atrophy. Invest Ophthalmol Vis Sci 57(14):6298\u20136304. https:\/\/doi.org\/10.1167\/iovs.16-20361","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"5849_CR6","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.oret.2020.01.019","volume":"4","author":"JS Heier","year":"2020","unstructured":"Heier JS, Pieramici D, Chakravarthy U, Patel SS, Gupta S, Lotery A, Lad EM, Silverman D, Henry EC, Anderesi M, Tschosik EA, Gray S, Ferrara D, Guymer R (2020) Visual Function decline resulting from geographic atrophy: results from the chroma and spectri phase 3 trials. Ophthalmol Retina 4(7):673\u2013688. https:\/\/doi.org\/10.1016\/j.oret.2020.01.019","journal-title":"Ophthalmol Retina"},{"issue":"10","key":"5849_CR7","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1097\/iae.0000000000001283","volume":"36","author":"SR Sadda","year":"2016","unstructured":"Sadda SR, Chakravarthy U, Birch DG, Staurenghi G, Henry EC, Brittain C (2016) Clinical endpoints for the study of geographic atrophy secondary to age-related macular degeneration. Retina (Philadelphia, Pa) 36(10):1806\u20131822. https:\/\/doi.org\/10.1097\/iae.0000000000001283","journal-title":"Retina (Philadelphia, Pa)"},{"key":"5849_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2147\/opth.S226425","volume":"14","author":"PJ Patel","year":"2020","unstructured":"Patel PJ, Ziemssen F, Ng E, Muthutantri A, Silverman D, Tschosik EA, Cantrell RA (2020) Burden of illness in geographic atrophy: a study of vision-related quality of life and health care resource use. Clin Ophthalmol (Auckland, NZ) 14:15\u201328. https:\/\/doi.org\/10.2147\/opth.S226425","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"issue":"1","key":"5849_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s40123-019-0160-3","volume":"8","author":"S Sivaprasad","year":"2019","unstructured":"Sivaprasad S, Tschosik EA, Guymer RH, Kapre A, Suner IJ, Joussen AM, Lanzetta P, Ferrara D (2019) Living with geographic atrophy: an ethnographic study. Ophthalmol Ther 8(1):115\u2013124. https:\/\/doi.org\/10.1007\/s40123-019-0160-3","journal-title":"Ophthalmol Ther"},{"issue":"5","key":"5849_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1167\/iovs.61.5.63","volume":"61","author":"SH K\u00fcnzel","year":"2020","unstructured":"K\u00fcnzel SH, M\u00f6ller PT, Lindner M, Goerdt L, Nadal J, Schmid M, Schmitz-Valckenberg S, Holz FG, Fleckenstein M, Pfau M (2020) Determinants of quality of life in geographic atrophy secondary to age-related macular degeneration. Invest Ophthalmol Vis Sci 61(5):63. https:\/\/doi.org\/10.1167\/iovs.61.5.63","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5849_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2018.03.006","volume":"190","author":"S Sivaprasad","year":"2018","unstructured":"Sivaprasad S, Tschosik E, Kapre A, Varma R, Bressler NM, Kimel M, Dolan C, Silverman D (2018) Reliability and construct validity of the NEI VFQ-25 in a Subset of Patients With Geographic Atrophy From the Phase 2 Mahalo Study. Am J Ophthalmol 190:1\u20138. https:\/\/doi.org\/10.1016\/j.ajo.2018.03.006","journal-title":"Am J Ophthalmol"},{"key":"5849_CR12","unstructured":"Kaiser E (2022) Tissue preservation should be considered as endpoint for geographic atrophy therapies. Modern Retina. https:\/\/www.modernretina.com\/view\/tissue-preservation-should-be-considered-as-endpoint-for-geographic-atrophy-therapies. Accessed June 12 2022"},{"issue":"8","key":"5849_CR13","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.oret.2020.11.003","volume":"5","author":"LL Shen","year":"2021","unstructured":"Shen LL, Sun M, Ahluwalia A, Young BK, Park MM, Toth CA, Lad EM, Del Priore LV (2021) Relationship of topographic distribution of geographic atrophy to visual acuity in nonexudative age-related macular degeneration. Ophthalmol Retina 5(8):761\u2013774. https:\/\/doi.org\/10.1016\/j.oret.2020.11.003","journal-title":"Ophthalmol Retina"},{"key":"5849_CR14","unstructured":"Iveric Bio Announces Presentation of post-hoc analysis from GATHER1 clinical trial of Zimura\u00ae in Patients with Geographic Atrophy. (2022) Businesswire. https:\/\/www.businesswire.com\/news\/home\/20220503006235\/en\/. Accessed June 12 2022"},{"key":"5849_CR15","doi-asserted-by":"publisher","unstructured":"Age-Related Eye Disease Study Research G (1999) The age-related eye disease study (AREDS): design implications. AREDS report no 1. Control Clin Trials 20(6):573\u2013600. https:\/\/doi.org\/10.1016\/s0197-2456(99)00031-8","DOI":"10.1016\/s0197-2456(99)00031-8"},{"key":"5849_CR16","doi-asserted-by":"publisher","unstructured":"Clemons TE, Chew EY, Bressler SB, McBee W, Age-Related Eye Disease Study Research G (2003) National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 10. Arch Ophthalmol 121(2):211\u2013217. https:\/\/doi.org\/10.1001\/archopht.121.2.211","DOI":"10.1001\/archopht.121.2.211"},{"issue":"11","key":"5849_CR17","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1001\/archopht.116.11.1496","volume":"116","author":"CM Mangione","year":"1998","unstructured":"Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD (1998) Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators Arch Ophthalmol 116(11):1496\u20131504. https:\/\/doi.org\/10.1001\/archopht.116.11.1496","journal-title":"NEI-VFQ Field Test Investigators Arch Ophthalmol"},{"issue":"5","key":"5849_CR18","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/s0002-9394(01)01218-1","volume":"132","author":"Age-Related Eye Disease Study Research G","year":"2001","unstructured":"Age-Related Eye Disease Study Research G (2001) The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. Am J Ophthalmol 132(5):668\u2013681. https:\/\/doi.org\/10.1016\/s0002-9394(01)01218-1","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"5849_CR19","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/s12859-017-1934-z","volume":"18","author":"CT Rueden","year":"2017","unstructured":"Rueden CT, Schindelin J, Hiner MC, DeZonia BE, Walter AE, Arena ET, Eliceiri KW (2017) Image J2: ImageJ for the next generation of scientific image data. BMC Bioinformatics 18(1):529. https:\/\/doi.org\/10.1186\/s12859-017-1934-z","journal-title":"BMC Bioinformatics"},{"issue":"9","key":"5849_CR20","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.oret.2020.12.002","volume":"5","author":"LL Shen","year":"2021","unstructured":"Shen LL, Sun M, Ahluwalia A, Young BK, Park MM, Del Priore LV (2021) Geographic atrophy growth is strongly related to lesion perimeter: unifying effects of lesion area, number, and circularity on growth. Ophthalmology Retina 5(9):868\u2013878. https:\/\/doi.org\/10.1016\/j.oret.2020.12.002","journal-title":"Ophthalmology Retina"},{"issue":"5","key":"5849_CR21","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1136\/bjophthalmol-2020-317636","volume":"106","author":"LL Shen","year":"2022","unstructured":"Shen LL, Sun M, Ahluwalia A, Park MM, Young BK, Lad EM, Toth C, Del Priore LV (2022) Natural history of central sparing in geographic atrophy secondary to non-exudative age-related macular degeneration. Br J Ophthalmol 106(5):689\u2013695. https:\/\/doi.org\/10.1136\/bjophthalmol-2020-317636","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"5849_CR22","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/ng1007-1181","volume":"39","author":"MD Mailman","year":"2007","unstructured":"Mailman MD, Feolo M, Jin Y, Kimura M, Tryka K, Bagoutdinov R, Hao L, Kiang A, Paschall J, Phan L, Popova N, Pretel S, Ziyabari L, Lee M, Shao Y, Wang ZY, Sirotkin K, Ward M, Kholodov M, Zbicz K, Beck J, Kimelman M, Shevelev S, Preuss D, Yaschenko E, Graeff A, Ostell J, Sherry ST (2007) The NCBI dbGaP database of genotypes and phenotypes. Nat Genet 39(10):1181\u20131186. https:\/\/doi.org\/10.1038\/ng1007-1181","journal-title":"Nat Genet"},{"key":"5849_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-022-02115-1","author":"S Sivaprasad","year":"2022","unstructured":"Sivaprasad S, Chandra S, Kwon J, Khalid N, Chong V (2022) Perspectives from clinical trials: is geographic atrophy one disease? Eye (Lond). https:\/\/doi.org\/10.1038\/s41433-022-02115-1","journal-title":"Eye (Lond)"},{"issue":"6","key":"5849_CR24","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.oret.2017.08.018","volume":"2","author":"QE Cheng","year":"2018","unstructured":"Cheng QE, Gao J, Kim BJ, Ying GS (2018) Design Characteristics of geographic atrophy treatment trials: systematic review of registered trials in ClinicalTrialsgov. Ophthalmol Retina 2(6):518\u2013525. https:\/\/doi.org\/10.1016\/j.oret.2017.08.018","journal-title":"Ophthalmol Retina"},{"issue":"6","key":"5849_CR25","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1001\/jamaophthalmol.2018.1544","volume":"136","author":"FG Holz","year":"2018","unstructured":"Holz FG, Sadda SR, Busbee B, Chew EY, Mitchell P, Tufail A, Brittain C, Ferrara D, Gray S, Honigberg L, Martin J, Tong B, Ehrlich JS, Bressler NM, Chroma Spectri Study I (2018) Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: chroma and spectri phase 3 randomized clinical trials. JAMA Ophthalmol 136(6):666\u2013677. https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.1544","journal-title":"JAMA Ophthalmol"},{"key":"5849_CR26","unstructured":"A Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham injections in patients with geographic atrophy (GA) Secondary to age-related macular degeneration. (2021) NIH U.S. National Library of Medicine. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03525613. Accessed June 5 2022"},{"issue":"3","key":"5849_CR27","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00417-020-04952-w","volume":"259","author":"S Kuester-Gruber","year":"2021","unstructured":"Kuester-Gruber S, Kabisch P, Cordey A, Karnath HO, Trauzettel-Klosinski S (2021) Training of vertical versus horizontal reading in patients with hemianopia - a randomized and controlled study. Graefes Arch Clin Exp Ophthalmol 259(3):745\u2013757. https:\/\/doi.org\/10.1007\/s00417-020-04952-w","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"5849_CR28","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1167\/iovs.14-15194","volume":"56","author":"C Huisingh","year":"2014","unstructured":"Huisingh C, McGwin G Jr, Wood J, Owsley C (2014) The driving visual field and a history of motor vehicle collision involvement in older drivers: a population-based examination. Invest Ophthalmol Vis Sci 56(1):132\u2013138. https:\/\/doi.org\/10.1167\/iovs.14-15194","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"5849_CR29","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1167\/iovs.10-5645","volume":"52","author":"P Orr","year":"2011","unstructured":"Orr P, Rentz AM, Margolis MK, Revicki DA, Dolan CM, Colman S, Fine JT, Bressler NM (2011) Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in age-related macular degeneration. Invest Ophthalmol Vis Sci 52(6):3354\u20133359. https:\/\/doi.org\/10.1167\/iovs.10-5645","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5849_CR30","doi-asserted-by":"publisher","unstructured":"Dong LM, Childs AL, Mangione CM, Bass EB, Bressler NM, Hawkins BS, Marsh MJ, Miskala P, Jaffee HA, McCaffrey LA, Submacular Surgery Trials Research G (2004) Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4. Am J Ophthalmol 138 (1):91\u2013108. https:\/\/doi.org\/10.1016\/j.ajo.2004.02.011","DOI":"10.1016\/j.ajo.2004.02.011"},{"key":"5849_CR31","doi-asserted-by":"publisher","unstructured":"Ahluwalia A, Shen LL, Del Priore LV (2021) Central geographic atrophy vs. neovascular age-related macular degeneration: differences in longitudinal vision-related quality of life. Graefes Arch Clin Exp Ophthalmol 259(2):307\u2013316. https:\/\/doi.org\/10.1007\/s00417-020-04892-5","DOI":"10.1007\/s00417-020-04892-5"},{"key":"5849_CR32","doi-asserted-by":"publisher","unstructured":"Sunness JS, Rubin GS, Broman A, Applegate CA, Bressler NM, Hawkins BS (2008) Low luminance visual dysfunction as a predictor of subsequent visual acuity loss from geographic atrophy in age-related macular degeneration. Ophthalmology 115(9):1480\u20131488, 1488 e1481\u20131482. https:\/\/doi.org\/10.1016\/j.ophtha.2008.03.009","DOI":"10.1016\/j.ophtha.2008.03.009"},{"issue":"13","key":"5849_CR33","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1167\/iovs.62.13.28","volume":"62","author":"LL Shen","year":"2021","unstructured":"Shen LL, Sun M, Ahluwalia A, Park MM, Young BK, Del Priore LV (2021) Local progression kinetics of geographic atrophy depends upon the border location. Invest Ophthalmol Vis Sci 62(13):28. https:\/\/doi.org\/10.1167\/iovs.62.13.28","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5849_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2021-319426","author":"LL Shen","year":"2021","unstructured":"Shen LL, Xie Y, Sun M, Ahluwalia A, Park MM, Young BK, Del Priore LV (2021) Associations of systemic health and medication use with the enlargement rate of geographic atrophy in age-related macular degeneration. Br J Ophthalmol. https:\/\/doi.org\/10.1136\/bjophthalmol-2021-319426","journal-title":"Br J Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05849-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-022-05849-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05849-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T11:40:16Z","timestamp":1678102816000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-022-05849-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["5849"],"URL":"https:\/\/doi.org\/10.1007\/s00417-022-05849-6","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,21]]},"assertion":[{"value":"12 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was exempted by the Yale Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"L. V. Del Priore, Consultant\u2014Astellas Institute for Regenerative Medicine, Boehringer Ingelheim; Scientific advisory board\u2014Cavthe Rx, LambdaVision, Tissue Regeneration Sciences; Scientific advisor\u2014Seeing Medicines; Research through university\u2014Stealth Pharmaceuticals. The other authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}